β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceFinancial Ratios
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Current Ratio | Quick Ratio | Cash Ratio | Days Of Sales Outstanding | Days Of Inventory Outstanding | Operating Cycle | Days Of Payables Outstanding | Cash Conversion Cycle | Gross Profit Margin | Operating Profit Margin | Pretax Profit Margin | Net Profit Margin | Effective Tax Rate | Return On Assets | Return On Equity | Return On Capital Employed | Net Income Per EBT | EBT Per EBIT | EBIT Per Revenue | Debt Ratio | Debt/Equity Ratio | Long Term Debt To Capitalization | Total Debt To Capitalization | Interest Coverage | Cash Flow To Debt Ratio | Company Equity Multiplier | Receivables Turnover | Payables Turnover | Inventory Turnover | Fixed Asset Turnover | Asset Turnover | Operating Cash Flow Per Share | Free Cash Flow Per Share | Cash Per Share | Payout Ratio | Operating Cash Flow / Sales Ratio | Free Cash Flow / Operating Cash Flow Ratio | Cash Flow Coverage Ratio | Short Term Coverage Ratios | Capital Expenditure Coverage Ratio | Dividend Paid And CAPEX Coverage Ratio | Dividend Payout Ratio | Price Book Value Ratio | Price To Book Ratio | Price To Sales Ratio | Price Earnings Ratio | Price To Free Cash Flows Ratio | Price To Operating Cash Flows Ratio | Price Cash Flow Ratio | Price Earnings To Growth Ratio | Price Sales Ratio | Dividend Yield | Enterprise Value Multiple | Price Fair Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 1.6 | 0.77 | 0.14 | 61.31 | 227.01 | 288.32 | 49.77 | 238.55 | 0.49 | 0.08 | 0.06 | 0.03 | 0.45 | 0.02 | 0.06 | 0.06 | 0.55 | 0.81 | 0.08 | 0.38 | 1.24 | 0.55 | 0.55 | 5.28 | 0.11 | 3.26 | 5.95 | 7.33 | 1.61 | 4.13 | 0.58 | 1.69 | 0.91 | 1.23 | 0.27 | 0.07 | 0.54 | 0.11 | 7.73 | 2.18 | 1.73 | 0.27 | 4.9 | 4.9 | 2.59 | 77.23 | 64.22 | 34.76 | 34.76 | -1.04 | 2.59 | 0 | 42.53 | 4.9 |
2023-12 | 1.8 | 0.99 | 0.41 | 76.56 | 243.54 | 320.1 | 50.98 | 269.12 | 0.51 | 0.15 | 0.18 | 0.14 | 0.22 | 0.1 | 0.31 | 0.14 | 0.79 | 1.25 | 0.15 | 0.32 | 1 | 0.45 | 0.5 | 26.64 | 0.25 | 3.09 | 4.77 | 7.16 | 1.5 | 4.29 | 0.7 | 2.39 | 1.66 | 3.34 | 0.07 | 0.12 | 0.69 | 0.25 | 2.89 | 3.28 | 2.57 | 0.07 | 7.81 | 7.81 | 3.63 | 25.18 | 44.23 | 30.73 | 30.73 | 0.55 | 3.63 | 0 | 19.45 | 7.81 |
2022-12 | 2.32 | 1.45 | 0.71 | 85.86 | 239.47 | 325.33 | 53.16 | 272.17 | 0.52 | 0.17 | 0.16 | 0.12 | 0.28 | 0.08 | 0.26 | 0.16 | 0.72 | 0.96 | 0.17 | 0.34 | 1.08 | 0.52 | 0.52 | 26.88 | 0.21 | 3.21 | 4.25 | 6.87 | 1.52 | 5.2 | 0.7 | 1.76 | 0.96 | 5.02 | 0.1 | 0.1 | 0.55 | 0.21 | 14.01 | 2.2 | 1.76 | 0.1 | 9.02 | 9.02 | 4.01 | 34.24 | 71.03 | 38.77 | 38.77 | 3.69 | 4.01 | 0 | 19.68 | 9.02 |
2021-12 | 2.63 | 1.88 | 1.14 | 62.93 | 214.51 | 277.44 | 44.53 | 232.91 | 0.5 | 0.17 | 0.16 | 0.11 | 0.29 | 0.08 | 0.26 | 0.15 | 0.7 | 0.95 | 0.17 | 0.37 | 1.23 | 0.53 | 0.55 | 28.9 | 0.21 | 3.37 | 5.8 | 8.2 | 1.7 | 5.95 | 0.66 | 1.87 | 1.26 | 7.72 | 0.09 | 0.12 | 0.67 | 0.21 | 2.51 | 3.07 | 2.43 | 0.09 | 11.71 | 11.71 | 5.25 | 45.85 | 66.72 | 44.99 | 44.99 | 0.59 | 5.25 | 0 | 26.09 | 11.71 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more ratios for Bruker!
Sign up for free or log inπ Claim your free eBook: "The Checklist Value Investor β A Smarter Way to Pick Stocks"